Fundraising Fox

Medsyn Biopharma

Northville, US · Delaware LLC

Biotech

Founders & leadership

JM
John Mel SorensenNamed on SEC filing
MS
Mel Sorensen JohnNamed on SEC filing
GS
Gilbert S. OmennNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$19.6M disclosed across 3 rounds · 2023–2025

▶$11.5MraisedNov 2025 · 16 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Martin MatthewExecutive Officer
  • Brian WoodExecutive Officer
  • John Mel SorensenExecutive Officer, Director
  • Shaomeng WangDirector
Offering amount
$11.5M
Amount sold
$11.5M
First sale
Oct 2025
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedAug 2024 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John Mel SorensenExecutive Officer, Director
Offering amount
$5M
Amount sold
$5M
First sale
Jul 2024
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.1MraisedMar 2023 · 6 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Mel Sorensen JohnExecutive Officer, Director
  • Gilbert S. OmennDirector
Offering amount
$3.1M
Amount sold
$3.1M
First sale
Feb 2023
Incorporated
Limited Liability Company, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Medsyn Biopharma raised?
Medsyn Biopharma has disclosed $19.6M raised across 3 rounds.
Where is Medsyn Biopharma headquartered?
Medsyn Biopharma is headquartered in Northville, US.